tradingkey.logo

IRadimed Corp

IRMD
View Detailed Chart
85.992USD
+1.882+2.24%
Market hours ETQuotes delayed by 15 min
1.09BMarket Cap
52.95P/E TTM

IRadimed Corp

85.992
+1.882+2.24%
Intraday
1m
30m
1h
D
W
M
D

Today

+2.24%

5 Days

+10.63%

1 Month

+20.71%

6 Months

+60.82%

Year to Date

+56.35%

1 Year

+78.04%

View Detailed Chart

TradingKey Stock Score of IRadimed Corp

Currency: USD Updated: 2025-11-03

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

IRadimed Corp's Score

Industry at a Glance

Industry Ranking
25 / 210
Overall Ranking
93 / 4617
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 2 analysts
Buy
Current Rating
82.500
Target Price
+7.41%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

IRadimed Corp Highlights

StrengthsRisks
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gausses.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 37.41% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 73.24M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 73.24M.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 29.64%.
Overvalued
The company’s latest PE is 51.69, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 7.53M shares, decreasing 9.83% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 27.00 shares of this stock.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

IRadimed Corp Info

IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gausses.
Ticker SymbolIRMD
CompanyIRadimed Corp
CEOMr. Roger Susi
Websitehttps://www.iradimed.com/
KeyAI